So the trial ended in Feb 2018. The verdict was that it would not replace standard procedure just yet.
I did like the feedback that users put forward. I think that is a good marker. The higher ups may resist until they can’t any longer.
I don’t think volpara is a huge ground swell yet - but the numbers still improve.
The newsletter said that they had a good quarter and are pleased and will release results in jan. this is coming into their busy quarters. That couple with confirmed leads being up this is a good sign. Chance to exceed guidance? Time will tell.
But being that the SP pushed up to 1.50 on some good volume people think it’s worth it.
2019 is break even. The sooner it happens the better for the SP
VHT Price at posting:
$1.10 Sentiment: Hold Disclosure: Held
